— Know what they know.
Not Investment Advice

PPH

VanEck Pharmaceutical ETF
1W: -2.6% 1M: -6.5% 3M: -1.7% YTD: +4.2% 1Y: +14.6% 3Y: +41.1% 5Y: +59.3%
$108.06
-0.08 (-0.07%)
 
Weekly Expected Move ±2.3%
$103 $106 $108 $111 $113
ETF NASDAQ · AUM $938.8M

Portfolio Health Summary

IS Overall Score
61.8
★★★★★
Altman Z-Score
4.97
Safe
Weight Coverage
100%
of portfolio analyzed
Holdings Matched
25
with fundamental data

InsiderStreet Scorecard

★★★★★ 61.8
Profitability
63.0
Balance Sheet
49.6
Earnings Quality
67.9
Growth
58.4
Value
42.0
Momentum
79.2
Safety
81.8

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
4.97
Safe Zone (>2.99)
Piotroski F-Score
6.8 / 9
Moderate
Beneish M-Score
-2.55
Unlikely Manipulator
Credit Score
—
Earnings Quality
67.9 / 100

Portfolio Valuation

P/E
17.96x
P/B
1.51x
P/S
1.67x
EV/EBITDA
13.39x
EV/Revenue
3.69x
P/FCF
11.40x
P/OCF
8.16x
PEG
1.07x
Earnings Yield
5.57%
FCF Yield
8.77%
OCF Yield
12.25%
Median P/E
21.31x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +15.5%
Net Income +31.5%
EPS +37.1%
FCF +56.9%
EBITDA +26.2%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +13.6%
Rev CAGR 5Y +10.8%
EPS CAGR 3Y +16.7%
EPS CAGR 5Y +11.5%
FCF CAGR 3Y +26.2%
FCF CAGR 5Y +13.3%
EBITDA CAGR 3Y +17.9%
EBITDA CAGR 5Y +14.2%
Payout Ratio
88.36%
Buyback Yield
1.02%
Dividend Yield
2.49%
Total Shareholder Return
2.80%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$108.06
Median 1Y
$118.47
5th Pctile
$88.75
95th Pctile
$158.20
Ann. Volatility
17.9%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 17.96
Portfolio P/B 1.51
Portfolio P/S 1.67
EV/EBITDA 13.39
EV/Revenue 3.69
P/FCF 11.40
P/OCF 8.16
PEG 1.07
Earnings Yield 5.57%
FCF Yield 8.77%
OCF Yield 12.25%
Median P/E 21.31
Profitability & Returns (9)
MetricValue
Gross Margin 61.00%
Operating Margin 16.56%
Net Margin 9.31%
FCF Margin 14.68%
ROE 8.85%
ROA 3.93%
ROIC 6.83%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 0.72
Debt/Assets 0.32
Net Debt/EBITDA 2.51
Interest Coverage 3.80
Current Ratio 1.11
Quick Ratio 0.68
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 15.51%
Net Income Growth 31.53%
EPS Growth 37.08%
FCF Growth 56.88%
EBITDA Growth 26.21%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 13.55%
Revenue CAGR 5Y 10.84%
Revenue CAGR 10Y —
EPS CAGR 3Y 16.73%
EPS CAGR 5Y 11.54%
EPS CAGR 10Y —
FCF CAGR 3Y 26.16%
FCF CAGR 5Y 13.34%
FCF CAGR 10Y —
EBITDA CAGR 3Y 17.88%
EBITDA CAGR 5Y 14.22%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 13.74%
Net Income CAGR 5Y 10.31%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 61.8
IS Profitability 63.0
IS Balance Sheet 49.6
IS Earnings Quality 67.9
IS Growth 58.4
IS Value 42.0
IS Momentum 79.2
IS Safety 81.8
IS Quality 71.8
Altman Z-Score 4.97
Piotroski F-Score 6.85
Beneish M-Score -2.55
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 2.49%
Payout Ratio 88.36%
Buyback Yield 1.02%
Total Shareholder Return 2.80%
Growth Stability (4)
MetricValue
Revenue Stability 0.742
Earnings Stability 0.419
Earnings Persistence 0.630
Margin Stability 0.942
Medians (3)
MetricValue
Median P/E 21.31
Median P/B 4.47
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 99.61%
Holdings Matched 25
Total Holdings 25

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms